Microchimerism following a blood transfusion (Transfusion-Associated Microchimerism - TA-MC) refers to the **long-term persistence of a small population of donor-derived cells** (typically white blood cells, especially lymphocytes or hematopoietic stem cells) in the recipient's circulation or tissues. This occurs when immunocompetent donor cells engraft in an **immunocompromised recipient** (e.g., trauma patients, those undergoing massive transfusion, or immunosuppressed individuals) who cannot completely eliminate them. The donor cells can persist for years at very low levels. **Potential Significance**: 1) **Graft-versus-Host Disease (GVHD)**: In rare cases, these donor lymphocytes could proliferate and cause TA-GVHD, although irradiation of blood products prevents this. 2) **Autoimmune or Inflammatory Diseases**: Some hypotheses suggest that long-term microchimerism might contribute to the development of autoimmune disorders (e.g., scleroderma) by inducing a chronic graft-versus-host-like reaction, but evidence is inconclusive. 3) **Tolerance**: Conversely, it might induce immunologic tolerance. 4) **Forensic Implications**: It can complicate DNA analysis. While usually benign, TA-MC is an area of ongoing research to understand its long-term health implications.

Break down complex topics into smaller, manageable chunks for easier recall.

Zambia

• Naomi Miselo – 31 pts

• Visual Pathway Lesions
• Positive and Negative Symptoms
• Hallucinations and Delusions
• Antipsychotic Medications
• Emergency: Environmental Emergencies